Key result
Long-term methyldopa controls blood pressure in severe pregnancy hypertension without apparent adverse fetal outcomes.
Observational
Answers are grounded in this paper and cite their sources.
Reports clinical experience with prolonged methyldopa treatment in pregnant women with severe hypertension, highlighting potential benefits for maternal safety and fetal outcomes.
Treatment with hypotensive drugs may be imperative for the safety of the mother when manifestations such as retinal haemorrhages develop during pregnancy. Even in malignant hypertension a successful pregnancy is possible when the blood-pressure is controlled (Kincaid-Smith et al., 1958). If there is no clear-cut indication that the mother requires treat ment, interest centres around the possibility that hypotensive drugs may improve the outlook for the foetus. Presumably the foetus and the placental circulation derive the maximum benefit from treatment begun early in the pregnancy. In this paper we report our experience with the long-term use of methyldopa in hypertensive pregnant women.
No takes yet. Share an insight, caveat, or question.
Kincaid‐Smith et al. (1966) conducted an observational in Severe hypertension in pregnancy. Methyldopa was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: